In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
Hanson
W L
WL
Cortech Inc., Denver, CO 80221, USA.
McCullough
R G
RG
Selig
W M
WM
Wieczorek
M
M
Ross
S
S
Whalley
E T
ET
Stewart
J M
JM
Gera
L
L
D000595:Amino Acid Sequence; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D004285:Dogs; D004355:Drug Stability; D005260:Female; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000378:metabolism
D065168:Bradykinin Receptor Antagonists; D009842:Oligopeptides; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; D001920:Bradykinin